drug · antibody
clazakizumab
Phase 3updated 5mo agoby $CSLLY CSL LTD🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 8 investigational indications.
targets
Interleukin-6
all catalysts(0)
nothing on the calendar yet
Trials studying clazakizumab
- phase2A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- phase2Improving Physical Function in Older Adults Using an Anti-inflammation Drug: The RIGHT Study
- phase3Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that